Clinical implications of mutational analysis in gastrointestinal stromal tumours
2008
Clinical Implications of Mutational Analysis in Gastrointestinal Stromal Tumours
publication
Evidence: moderate
Author Information
Author(s): Hoeben A, Schöffski P, Debiec-Rychter M
Primary Institution: Catholic University of Leuven, Leuven, Belgium
Hypothesis
The study investigates the role of KIT and PDGFRA mutational analysis in the diagnosis and treatment of gastrointestinal stromal tumours (GISTs).
Conclusion
Mutational analysis of GISTs is essential for effective diagnosis and treatment, influencing prognosis and response to therapies.
Supporting Evidence
- GISTs are the most common mesenchymal tumours of the gastrointestinal tract.
- Identification of KIT mutations has changed the diagnosis and treatment of GIST.
- Mutational analysis is recommended for primary intermediate or high-risk GISTs.
Takeaway
This study shows that understanding the mutations in GISTs helps doctors choose the best treatment for patients.
Methodology
The review summarizes current data on the role of molecular characterization in GISTs.
Limitations
The global nonavailability of standardized mutational analysis methods is a significant limitation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website